Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility. - Wikidata - awgldk - TriplyDB

Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility.

Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility.

http://www.wikidata.org/entity/Q37409916

about

Plasmodium falciparum susceptibility to antimalarial drugs: global data issued from the Pasteur Institutes international network Analogs of natural aminoacyl-tRNA synthetase inhibitors clear malaria in vivo PfCRT and its role in antimalarial drug resistance Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase: a unique bifunctional enzyme from Plasmodium falciparum A genome wide association study of Plasmodium falciparum susceptibility to 22 antimalarial drugs in Kenya Plasmodium falciparum drug resistance in Angola RDTs as a source of DNA to study Plasmodium falciparum drug resistance in isolates from Senegal and the Comoros Islands Chloroquine clinical failures in P. falciparum malaria are associated with mutant Pfmdr-1, not Pfcrt in Madagascar High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool.Travel and the emergence of high-level drug resistance in Plasmodium falciparum in southwest Uganda: results from a population-based study.The epidemiological transition in Antananarivo, Madagascar: an assessment based on death registers (1900-2012)Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa Origins of the recent emergence of Plasmodium falciparum pyrimethamine resistance alleles in Madagascar.Progressive increase in point mutations associates chloroquine resistance: Even after withdrawal of chloroquine use in India Synthesis, structure-activity relationship, and mode-of-action studies of antimalarial reversed chloroquine compounds.Double mutation in the pfmdr1 gene is associated with emergence of chloroquine-resistant Plasmodium falciparum malaria in Eastern India A chemotype that inhibits three unrelated pathogenic targets: the botulinum neurotoxin serotype A light chain, P. falciparum malaria, and the Ebola filovirus.Temporal and seasonal changes of genetic polymorphisms associated with altered drug susceptibility to chloroquine, lumefantrine, and quinine in Guinea-Bissau between 2003 and 2012 Drug resistance maps to guide intermittent preventive treatment of malaria in African infants.In vitro susceptibility to pyrimethamine of DHFR I164L single mutant Plasmodium falciparum Persistence of chloroquine-resistant haplotypes of Plasmodium falciparum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine.Molecular epidemiology and seroprevalence in asymptomatic Plasmodium falciparum infections of Malagasy pregnant women in the highlands Reduced impact of pyrimethamine drug pressure on Plasmodium malariae dihydrofolate reductase gene.Comparative efficacies of artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps genes in tea gardens of Jalpaiguri District, India Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010.High prevalence of asymptomatic malaria in a tribal population in eastern India.Association between prevalence of chloroquine resistance and unusual mutation in pfmdr-I and pfcrt genes in India.Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine Survey of Plasmodium falciparum multidrug resistance-1 and chloroquine resistance transporter alleles in Haiti.Role of Different Pfcrt and Pfmdr-1 Mutations in Conferring Resistance to Antimalaria Drugs in Plasmodium falciparum.Phylogenomics of phosphoinositide lipid kinases: perspectives on the evolution of second messenger signaling and drug discovery Are Antimalarial Hybrid Molecules a Close Reality or a Distant Dream?[Comparison of efficacy of chloroquine versus sulfadoxine-pyrimethamine in malaria prevention in pregnant women in the Toamasina region (Madagascar)].Drug-Resistant Polymorphisms and Copy Numbers in Plasmodium falciparum, Mozambique, 2015.Genetic profiling of the Plasmodium falciparum population using antigenic molecular markers.Efficacy of artesunate-amodiaquine in the treatment of falciparum uncomplicated malaria in Madagascar Efficacy of artemisinin-based combination therapies and prevalence of molecular markers associated with artemisinin, piperaquine and sulfadoxine-pyrimethamine resistance in Sierra Leone

P2860

Q26860875-D07640D0-3125-472C-B24D-32E0B3393A6F Q27861933-B1F363A0-4011-4EF9-96F4-A9ED72E46083 Q27861957-EC61E894-E3D6-4F42-9FE9-3ECDD8028F9E Q27974087-6B1059AE-8503-44E6-A809-0064DA2D77BC Q28031418-D997A0FC-169D-47AB-8E89-73EF4900C82D Q28075079-78AE7171-34F3-431A-93BE-E0C990680FC9 Q28125925-5CEFE0AF-5BCC-46F4-8228-22A3DC0160ED Q28475757-ABF1C035-CFC7-4BA5-A7D8-2536BF2D00CF Q30619647-6CE829AE-341D-4CAF-894A-44B87A9440C2 Q33568493-3E50BB34-4847-40AB-8775-9C143A89B24E Q33641495-3F54B448-AFAD-4A2A-92AE-162C0D06112D Q33817484-98C4EDE7-7875-4078-A4D6-0E76E36DACB3 Q33876441-A48CE242-B05C-4EC4-BE96-87A6DE4CC61E Q33889755-B9CB52CA-1871-4D0C-A978-2282BA1FC6C0 Q34129945-62ACFF86-267B-4448-86FC-4C2D31535FFE Q34298884-A4AF634F-42BF-4F26-8F2B-0511E1F62F3C Q34665879-E4D4B5BC-9F8C-4A75-B20A-3ACDC03D8066 Q35105975-4E50C15F-C8AE-4D7C-809F-650EA38CC98A Q35228689-485AC7DD-A816-42C3-8207-0D0FEDA24F40 Q35338819-73850B12-3789-4133-816E-C2D861D18EB1 Q35545210-2C19D2C7-CDC3-4068-82E7-0BA8FD6C140E Q35610130-AA7F6B93-8A09-4F06-8015-7A1C803DE850 Q35689218-ECF465C1-B539-4019-A080-8D0DB00A2022 Q35941354-8AB991BF-012D-4603-95F8-BBEB8CC96287 Q36558557-29FE4B11-E61D-4C31-BAF8-C2DC1CE6BDC5 Q36826719-A84A7351-5325-4531-AD7B-22A4CE14EF4C Q37119368-FBAFCB8D-FF4B-414C-AB6E-73D1616EF7EF Q37178300-120DD927-8D45-405A-A1F4-BA23B90B91C7 Q37427816-AE53D524-04B8-4429-A965-2FE11C2F5E0E Q38288177-48B4D5AC-5947-4CE1-842F-0D29933DDA6E Q38503780-F179B386-1C85-4440-AF57-CD7E48306F66 Q39176524-7602346F-4579-4264-BFA4-BD30C19EAB50 Q41427482-281A6FBE-EABA-4F1E-91A3-7656525BE898 Q48019828-C209C744-1E62-434E-AA6D-46E9D839055D Q55616717-4E70658C-54E1-474A-89BE-F2636BFA1C15 Q56346944-2170E57A-75CC-4A49-8FE5-9FB33FF9F47A Q56376468-90534CFD-AA9D-4E26-9E5E-5D8F7C2F5877

P2860

Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility.

http://www.wikidata.org/entity/Q37409916

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 August 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Plasmodium falciparum drug res ...... droartemisinin susceptibility.

@en

Plasmodium falciparum drug res ...... droartemisinin susceptibility.

@nl

type

label

Plasmodium falciparum drug res ...... droartemisinin susceptibility.

@en

Plasmodium falciparum drug res ...... droartemisinin susceptibility.

@nl

prefLabel

Plasmodium falciparum drug res ...... droartemisinin susceptibility.

@en

Plasmodium falciparum drug res ...... droartemisinin susceptibility.

@nl

P1433

Q37409916-0F49C2BB-522D-4EB0-AF66-C262E6D41DB1

P1476

Q37409916-A5A23EBA-3F54-4180-A411-D5EB27EC70A6

P2093

Q37409916-61EB96E7-9C93-459E-A327-2C906D87169A

Q37409916-86B3704A-B0C4-4389-AF82-3C2D0A2803A0

Q37409916-9CA2D2CA-6FD9-40F9-BE34-1C2B7D6D5A44

Q37409916-A1A5131C-46E2-4378-8BEF-2C6D6550E8BA

Q37409916-E6C1441C-0C1A-422F-97A6-72F631CCE1BD

Q37409916-EE50BA87-05E1-48F1-8076-81D8EC86F8A9

P2860

Q37409916-03A4CE78-C489-4D08-8E62-FAF00C554D8C

Q37409916-03DBC016-A56F-4C58-9D7C-70D73040A1F5

Q37409916-04B3501A-B4F0-4BE7-8501-DAD91F0AA274

Q37409916-14B7BA1A-1667-41DC-B52D-F52FE9C171C3

Q37409916-1D5AD7ED-2F31-4C8E-97D5-5E92C966C0DA

Q37409916-22D6AD0A-D275-4322-BA64-C9C27468778A

Q37409916-26FDFC65-58D5-47DA-85E4-E2FAC41AC124

Q37409916-33A5B8F7-541F-4EC8-ADD6-0307B4F80A06

Q37409916-3A73A63B-7841-4FD8-8830-CA1399CF56F8

Q37409916-3C2BF69F-5C34-4626-B5C1-A9E12B7EEF30

P304

Q37409916-D6F27E79-2A45-4339-A9F0-510A8BC2684E

P31

Q37409916-EA1F786D-147F-42F6-814F-65E5C4D85173

P356

Q37409916-677B6C9F-5C21-4598-823D-040D2CC23E1C

P407

Q37409916-81509DFC-2D24-4EBF-A0E7-9BC9AAB8161B

P433

Q37409916-54CE21BD-3BFA-4C3D-9462-B9A3B9ED5208

P478

Q37409916-03956C8B-9F5E-426F-9F76-57C85C0E322E

P50

Q37409916-18C1E626-8E82-4B5C-8D4A-B2B0E8E045B7

Q37409916-45321F6D-4E65-4D4B-9E4B-AA3BBC00699E

Q37409916-4874C5AB-C8ED-42D7-99BD-B624BA6B8A24

Q37409916-4C3B05ED-C198-43C6-9E94-7EF3CB6DB34A

Q37409916-62E359DB-58F6-451B-981A-184BFDB47285

Q37409916-BA81ABBC-BEB7-423E-A671-B3019411A13C

Q37409916-D2C7C536-BED7-46F1-B6E9-3207CD4483F2

Q37409916-EE9448E8-FAA0-406A-8826-4E447C92E3E1

P577

Q37409916-3F5F6DBB-7DDA-4E0A-843E-2F6171518AE3

P698

Q37409916-E2C282CD-5B35-46DC-B9A0-7A28A98FFC95

P921

Q37409916-088690B8-9FA6-4673-AF8A-EB9B29309ABE

Q37409916-A58B61E7-F576-4F8C-A644-8F952C16E7AB

Q37409916-D6F53B1A-E93B-448A-8718-47495C85E219

P932

Q37409916-4081691E-B51A-4196-9005-F392DB397E02

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Plasmodium falciparum drug res ...... droartemisinin susceptibility.

@en

P2093

Léon Paul Rabarijaona

http://www.w3.org/2001/XMLSchema#string

Marie Ange Rason

http://www.w3.org/2001/XMLSchema#string

Rogelin Radrianjafy

http://www.w3.org/2001/XMLSchema#string

Rémy Durand

http://www.w3.org/2001/XMLSchema#string

Tantely Randriantsoa

http://www.w3.org/2001/XMLSchema#string

Voahangy Andrianaranjaka

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum

Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number

Antimalarial drug use in general populations of tropical Africa.

World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria.

Assessment of the efficacy of antimalarial drugs recommended by the National Malaria Control Programme in Madagascar: up-dated baseline data from randomized and multi-site clinical trials.

The past, present and future of childhood malaria mortality in Africa.

First evidence of pfcrt mutant Plasmodium falciparum in Madagascar.

Combating malaria in Africa.

The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum.

P304

4588-4597

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00610-09

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P50

Odile Mercereau-Puijalon

Christiane Bouchier

Stéphane Rabearimanana

Arsène Ratsimbasoa

Valérie Andriantsoanirina

Martial Jahevitra

P577

2009-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19704124

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium falciparum

P932

2772329

http://www.w3.org/2001/XMLSchema#string